CD8A and influenza: Conventional SARS-CoV-2 and influenza vaccines based on inactivated virions or viral protein fragments, such as PiCoVacc, BBIBP-CorV, and NVX-CoV2373, are effective in inducing antibody responses, but not T-cell responses, particularly CD8+ T cells67–70.